Clinical Trials Logo

Filter by:
NCT ID: NCT01516957 Terminated - Psoriatic Arthritis Clinical Trials

AMG 827 in Subjects With Psoriatic Arthritis

Start date: October 2011
Phase: Phase 2
Study type: Interventional

The study will examine the safety and effectiveness of AMG 827 for the treatment of psoriatic arthritis

NCT ID: NCT01516554 Terminated - Multiple Sclerosis Clinical Trials

Oral Testosterone for Fatigue in Male Multiple Sclerosis Patients

Start date: February 2012
Phase: Phase 2
Study type: Interventional

Fatigue is one of the most frequent symptoms reported by multiple sclerosis (MS) patients and is often a significant source of disability. Unlike normal fatigue, multiple sclerosis related fatigue (MSRF) occurs independently of activity level, suggesting that it is due to dysfunction in the neural pathways that regulate the perception of energy although the precise cause is still not understood. While MSRF can be managed through lifestyle modifications and with drug treatment, these measures are commonly either ineffective or only partially effective. Administration of the male sex hormone testosterone has been shown to improve energy levels in males with testosterone-deficiency states. Testosterone also reduces fatigue in patients with other medical conditions not associated with low testosterone levels, suggesting that this treatment may also be useful in symptomatic control of MSRF. This proposed seven-month long clinical trial is designed to test the hypothesis that administration of oral testosterone tablets to male MS patients will result in an improvement of fatigue relative to the administration of placebo tablets. As fatigue is frequently reported by MS patients to be one of their most frustrating and disabling symptoms, any proven additional treatment option for MSRF would be beneficial in improving quality of life.

NCT ID: NCT01514864 Terminated - Clinical trials for Carcinoma, Non-small Cell Lung

Trial of Dasatinib in Patients With Advanced Cancers Harboring DDR2 Mutation or Inactivating B-RAF Mutation

Start date: May 31, 2012
Phase: Phase 2
Study type: Interventional

The purpose of this study is to establish whether patients with malignancy harboring a discoidin domain receptor 2 mutation or an inactivating B-RAF mutation will respond to dasatinib.

NCT ID: NCT01514149 Terminated - Clinical trials for Type 2 Diabetes Mellitus (T2DM)

Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

Start date: August 2011
Phase: Phase 2
Study type: Interventional

DM200-103 is a dose-ranging study to evaluate the efficacy and safety of 17 weeks of weekly injections of CJC-1134-PC in patients with Type 2 Diabetes Mellitus on metformin monotherapy.

NCT ID: NCT01512472 Terminated - Clinical trials for Prostate Cancer Recurrent

Firmagon (Degarelix) Intermittent Therapy

FIT
Start date: January 2012
Phase: Phase 4
Study type: Interventional

Men with localized prostate cancer requiring intermittent androgen deprivation therapy for biochemical recurrence following radical therapy will be asked to participate in a phase 4 safety and efficacy clinical trial comparing 10 months versus 4 months of degarelix (Firmagon®) therapy with the endpoint of prolonging the off treatment interval.

NCT ID: NCT01510184 Terminated - Clinical trials for Diffuse Large B-cell Lymphoma

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Start date: April 19, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Zevalin compared with observation alone in participants who are in PET-negative complete remission after first-line R-CHOP or R-CHOP like therapy.

NCT ID: NCT01509053 Terminated - Schizophrenia Clinical Trials

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

ARRIVE- EU
Start date: January 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare retrospective hospitalization rates of schizophrenic patients treated with oral antipsychotics to prospective hospitalization rates of these patients treated with IM depot aripiprazole.

NCT ID: NCT01506401 Terminated - Clinical trials for Acute Respiratory Distress Syndrome (ARDS)

The Oscillation for Acute Respiratory Distress Syndrome (ARDS) Treated Early (OSCILLATE) Trial

OSCILLATE
Start date: June 2009
Phase: Phase 3
Study type: Interventional

What is the effect of early high frequency oscillation (HFO) versus a lung-protective conventional ventilation (CV) strategy (using HFO only as rescue therapy), on all-cause hospital mortality among patients with severe early acute respiratory distress syndrome (ARDS)?

NCT ID: NCT01505881 Terminated - Thromboembolism Clinical Trials

Follow on Study From RE-ALIGN

Start date: December 2011
Phase: Phase 2
Study type: Interventional

To collect additional data relating to safety and indicators of efficacy for patients who have participated in the 1160.113 study.

NCT ID: NCT01504308 Terminated - Uterine Fibroids Clinical Trials

Sonalleve Fibroid Ablation Pivotal Clinical Trial for MR-HIFU of Uterine Fibroids

SOFIA
Start date: May 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this clinical study is to determine whether treatment with the Philips Sonalleve Magnetic Resonance-guided High Intensity Focused Ultrasound (MR-HIFU) system is effective in the treatment symptomatic uterine leiomyomas (uterine fibroids).